BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8623414)

  • 1. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
    Wright JR; Kearns H; McDonald AS
    Transplant Proc; 1994 Jun; 26(3):1310. PubMed ID: 8029918
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
    Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of different temporary immunosuppressive therapies and low-temperature culture on pancreatic islet xenograft survival (pig-to-mouse).
    Marchetti P; Scharp DW; Finke E; Swanson CJ; Gerasimidi-Vazeou A; Olack BJ; Navalesi R; Lacy PE
    Transplant Proc; 1994 Apr; 26(2):760-1. PubMed ID: 8171651
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo function of pig islet xenografts in immunosuppressed diabetic mice.
    Tai J; Cheung SS; Tsang A; Tze WJ
    Transplant Proc; 1995 Dec; 27(6):3316-7. PubMed ID: 8539968
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of rapamycin on islet xenograft survival.
    Lu X; Schuurman HJ; Borel JF
    Transplant Proc; 1994 Jun; 26(3):1128-9. PubMed ID: 8029857
    [No Abstract]   [Full Text] [Related]  

  • 10. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract]   [Full Text] [Related]  

  • 11. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
    Zhang L; Qi Z; Wu D; Shan S; Ekberg H
    Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
    Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation and fish-to-mouse islet xenograft survival.
    Wright JR; Kearns H
    Transplant Proc; 1994 Dec; 26(6):3489. PubMed ID: 7998240
    [No Abstract]   [Full Text] [Related]  

  • 15. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
    Ohzato H; Porter J; Monaco AP; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats.
    Sung RS; Fiedor PS; Yaron I; Zakheim AR; Quadracci KM; Goodman ER; Hardy MA
    Transplant Proc; 1996 Apr; 28(2):839. PubMed ID: 8623427
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged functional survival of rat-to-NOD mouse islet xenografts by ultraviolet-B (UV-B) irradiation plus microencapsulation of donor islets.
    Weber C; Krekun S; Koschitzky T; Zabinski S; D'Agati V; Hardy M; Reemtsma K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):764-6. PubMed ID: 1990683
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of direct and indirect antigen presentation in the response to islet xenografts.
    Gill RG
    Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
    [No Abstract]   [Full Text] [Related]  

  • 19. Engraftment and survival of human islet xenografts irradiated with ultraviolet B in immunocompetent diabetic mice.
    Sung RS; Fiedor PS; Yaron I; Zakheim AR; Quadracci KM; Goodman ER; Hardy MA
    Transplant Proc; 1995 Dec; 27(6):3295-6. PubMed ID: 8539961
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-CD4 antibody treatment in xenografts of differently immunomodulated porcine islets.
    Marchetti P; Scharp DW; Finke E; Swanson CJ; Gerasimidi-Vazeou A; Olack BJ; Navalesi R; Lacy PE
    Transplant Proc; 1994 Jun; 26(3):1132. PubMed ID: 8029858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.